Contrast-Induced Nephropathy

Indian Heart Journal

Volumn 56, Issue 1, 2004, Pages 13-20

  Narang, R ^a   Sakhare, M ^a   Bahl, V K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; ACETYLCYSTEINE; AMLODIPINE; ATRIAL NATRIURETIC FACTOR; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CONTRAST MEDIUM; DIATRIZOATE; DOPAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; FENOLDOPAM; FUROSEMIDE; GADOLINIUM CHELATE; IODIXANOL; IOHEXOL; IOPROMIDE; IOTROLAN; LOOP DIURETIC AGENT; MANNITOL; MEGLUMINE DIATRIZOATE; THEOPHYLLINE;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORRELATION ANALYSIS; DIABETES MELLITUS; DIALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG HALF LIFE; EDITORIAL; HEMODIALYSIS; HEMOFILTRATION; HUMAN; INCIDENCE; KIDNEY DISEASE; KIDNEY DYSFUNCTION; MORTALITY; NEPHROTOXICITY; NONHUMAN; OSMOSIS; PAIN; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; RISK ASSESSMENT; RISK FACTOR; TOXICITY;

CONTRAST MEDIA; CORONARY DISEASE; HEMOFILTRATION; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE; OSMOLAR CONCENTRATION; RADIOLOGY, INTERVENTIONAL; RENAL DIALYSIS; RISK FACTORS;

EID: 1942533603     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (40)

1. D'Elia JA, Gleason RE, Alday M, Malarick C, Godley K, Warram J, et al. Nephrotoxicity from angiographic contrast material: a prospective study. Am J Med 1982; 72: 719-725
2. Porter GA. Radiocontrast-induced nephropathy. Nephrol Dial Transplant 1994; 9 (Suppl 4): 146-156
3. Barrett BJ, Parfrey PS, Vavasour HM, McDonald J, Kent G, Hefferton D, et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992; 41: 1274-1279
4. Lautin EM, Freeman NJ, Schoenfeld AH, Bakal EW, Haramati N, Friedman AC, et al. Radiocontrast associated renal dysfunction: Incidence and risk factors. AJR Am J Roentgenol 1991; 157: 49-58
5. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-2264
6. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-375
7. Gruberg L, Mehran R, Dangas G, Mintz GS, Waksman R, Kent KM, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 2001; 52: 409-416
8. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: A cohort analysis. JAMA 1996; 275: 1489-1494
9. Mehran R, Dangas G, Gruberg L, Lansky AJ, Okubagzi P, Astatkie M, et al. The detrimental impact of chronic renal insufficiency and diabetes mellitus on late prognosis after Percutaneous coronary interventions [Abstr]. J Am Coll Cardiol 2000; 35: A73
10. Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, et al. The prognostic implications of further renal function deterioration within 48h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000; 36: 1542-1548
11. Gruberg L, Dangas G, Mehran R, Mintz GS, Kent KM, Pichard AD, et al. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv 2002; 55: 66-72
12. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative study. Kidney Int 1995; 47: 254-261
13. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: A prospective controlled study. N Engl J Med 1989; 320: 143-149
14. Davidson CJ, Hlatky M, Morris KG, Pieper K, Skelton TN, Schwab SJ, et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization: A prospective trial. Ann Intern Med 1989; 110: 119-124
15. Berns AS. Nephrotoxicity of contrast media. Kidney Int 1989; 36: 730-740
16. Barrett BJ, Carlisle EJ. Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993; 188: 171-178
17. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491-499
18. Clauss W, Dinger J, Meissner C. Renal tolerance of iotrolan-280. Eur Radiol 1995; 5: S79-S84
19. Chalmers N, Jackson RW. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 1999; 72: 701-703
20. Nyman U, Elmstahl B, Leander P, Nilsson M, Golman K, Almen T. Are gadolinium-based contrast media really safer than iodinated media for digital substraction angiography in patients with azotemia? Radiology 2002; 223: 311-318
21. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, et al. Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-336
22. Taylor AJ, Hotchkiss D, Morse RW, McCabe J. PREPARED: Preparation for angiography in renal dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mid-to-moderate renal dysfunction. Chest 1998; 114: 1570-1574
23. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-1420
24. Tumlin JA, Wang A, Murray PT, Mathur VS. Fenoldopam blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. Am Heart J 2002; 143: 894-903
25. Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, et al. for CONTRAST Investigators. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: A randomized controlled trial. JAMA 2003; 290: 2284-2291
26. Baker C, Wragg A, Kumar S, De Palma R, Baker LR, Knight CJ. A rapid protocol for the prevention of contrast-induced renal dysfunction. The RAPPID study. J Am Coll Cardiol 2003; 41: 2114-2118
27. Shyu KG, Cheng JJ, Kaun P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 2002; 40: 1383-1388
28. Birck R, Krzossok S, Markowetz F, Schnulle P, van der Woude FJ, Braun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003; 362: 598-603
29. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W, et al. Prevention of radiographic contrast agent induced reductions in renal function by acetylcystiene. N Engl J Med 2000; 343: 180-184
30. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 2002; 89: 356-358
31. Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, et al. Prospective randomized study of N-acetylcysteine, fenoldopam and saline for prevention of contrast-induced nephropathy. Catheter Cardiovasc Intervt 2002; 57: 279-283
32. Durham JD, Caputo C, Dokko J, Zaharakist T, Pahlavan M, Keltz J, et al. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 2002; 62: 2202-2207
33. Carraro M, Mancini W, Artero M, Stacul F, Grutto M, Cova M, et al. Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic contrast administration. Neprhol Dial Transplant 1996; 11: 444-448.
34. Erley CM, Duda Sh, Rehfuss D, Scholtes B, Bock J, Muller C, et al. Prevention of radiocontrast media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant 1999; 14: 1146-1149
35. Kapoor A, Kumar S, Gulati S Gambhir S, Sethi RS, Sinha N. The role of theophylline in contrast-induced nephropathy: A case-control study. Nephrol Dial Transplant 2002; 17: 1936-1941
36. Kurnik BR, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS, et al. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 1998; 31: 674-680
37. Wang A, Holcslaw T, Bashore TM, Freed MI, Miller D, Rudnick MR, et al. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 2000; 57: 1675-1680
38. Gupta RK, Kapoor A, Tewari S et al. Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study. Ind Heart J 1999; 51: 521-526
39. Vogt B, Ferrari P, Schonholzer C, Marti HP, Mohaupt M, Wiederkehr M, et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001; 111: 692-698
40. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003; 349: 1333-1340